Eli Lilly reached an undisclosed financial settlement Wednesday in a case brought by the Melnick sisters. They believe their breast cancer was caused by a synthetic estrogen known as DES, which was prescribed to millions of women to prevent miscarriages.
The sisters' case was the first to go to trial out of dozens filed nationwide.
Eli Lilly says it believes its medication "did not cause the conditions alleged in this lawsuit," but the settlement was in its best interest.
Irene Sawyer, of Columbus, Ohio, calls the settlement a "huge victory."